Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Spybiotech Limited is currently navigating the patent prosecution process within the Biotechnology & Pharmaceuticals technology area. The portfolio contains 1 pending office action that requires attention. This action is under the review of FOLEY, SHANON A, who is the busiest examiner for the company's active applications.
The prosecution is organized around 1 distinct examiner and a distinct art unit. FOLEY, SHANON A is the examiner responsible for the pending office action. This concentration means that the company's patent strategy is currently focused on a set of technical and procedural requirements. Such a narrow focus can allow for a personalized approach to examiner interviews and amendments.
The involvement of a distinct art unit indicates that the company's technology is being evaluated within a specialized group. Practitioners should monitor the specific trends within this art unit to better anticipate potential rejections. With the pending office action representing the entire current workload, its successful resolution is critical for the portfolio's development.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOLEY, SHANON A | 1 | 73.3% | +18.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558898 | ADENOVIRAL VECTORS AND VACCINES THEREOF | FOLEY, SHANON A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18558898 | ADENOVIRAL VECTORS AND VACCINES THEREOF | FOLEY, SHANON A | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18558898 | ADENOVIRAL VECTORS AND VACCINES THEREOF | FOLEY, SHANON A | 1671 | §103§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial